EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Evaluating the role of faecal calprotectin in older adults: a retrospective observational study

Robert W Perry iD, Peter Fg Foulser, David Zhang, Pablo Martinez Perez, Shakira Taylor, Angelica Sharma iD, Mithun Kumaran, Sharmili Balarajah iD, Shiva T Radhakrishnan iD, Rohan Sundramoorthi, Carmen My Chung iD, David Mummery iD und 4 weitere

British Journal of General Practice · 2026

DOI: 10.3399/bjgp.2025.0169 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift British Journal of General Practice, 2026. Verfasst von Robert W Perry und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK robert.perry@imperial.ac.uk. Hauptthemen laut MEDLINE: Leukocyte L1 Antigen Complex, Feces, Colorectal Neoplasms, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Faecal calprotectin (FC) is a marker of gastrointestinal (GI) inflammation that is widely used in primary care to identify patients who need to be referred for endoscopic assessment. Most guidelines advise against its use in older adults because of higher rates of colorectal cancer (CRC) in this group, and many studies include only younger adults, even though FC is still used in older adults.

Aim

To evaluate FC performance in identifying inflammatory bowel disease (IBD) and significant organic pathology in adults aged ≥50 years, to help inform its use and interpretation in primary care. Where available, faecal immunochemical test (FIT) data were also analysed. Design and setting A retrospective observational study of patients who were referred from primary care to secondary care for colonoscopy at Imperial College Healthcare NHS Trust.

Method

Patients who had undergone FC testing, followed by a colonoscopy, were recruited and grouped into younger adults (aged 18–49 years) and older adults (aged ≥50 years). Data were then collected using electronic health records to allow for analysis of FC diagnostic performance.

Results

In total, 669 patients were included: 423 aged 18–49 years and 246 aged ≥50 years. There were no significant differences in FC levels between the groups (median FC level: 71 µg/g versus 85.5 µg/g respectively, P = 0.29). An FC level of >50 µg/g showed a high sensitivity for inflammatory bowel disease (IBD) in both groups (94.1% in those aged 18–49 years and 93.8% in those aged ≥50 years), but the positive predictive value was low — particularly in those aged ≥50 years (12.8%) versus the younger cohort (20.9%). An FC level of >50 µg/g outperformed FIT (threshold 10 µg/g) for the diagnosis of IBD and organic pathology in both groups. However, in patients aged ≥50 years, FIT outperformed FC at 150 µg/g for the diagnosis of organic pathology, including CRC.

Conclusion

These data show that FC remains a sensitive test in older adults. FC may have a role as a ‘rule-out’ test in adults aged ≥50 years who have lower GI symptoms and a negative FIT, when CRC is not suspected.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukocyte L1 Antigen ComplexFecesColorectal NeoplasmsInflammatory Bowel DiseasesHumansRetrospective StudiesMiddle AgedMaleFemaleAdultColonoscopyBiomarkersAgedPrimary Health CareSensitivity and SpecificityAge Factors

Stichwörter der Autor:innen

faecal calprotectinfaecal immunochemical testgastroenterologyinflammatory bowel diseasesprimary care

Substanzen

Leukocyte L1 Antigen ComplexBiomarkers

Autor:innen und Institutionen

  • Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK robert.perry@imperial.ac.uk.
  • Departments of Gastroenterology and Hepatology, St Mary's Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK.
  • Northwick Park Hospital, London North West University Healthcare NHS Trust, Harrow, UK.
  • Department of Primary Care and Public Health, Imperial College London, London, UK.
  • St Mark's Hospital, Central Middlesex, London, UK.

ORCID-Profile: Robert W Perry, Angelica Sharma, Sharmili Balarajah, Shiva T Radhakrishnan, Carmen My Chung, David Mummery, James L Alexander, Azeem Majeed, Lucy C Hicks, Horace Rt Williams

Zitieren

APA

Perry, R. W., Foulser, P. F., Zhang, D., Martinez Perez, P., Taylor, S., Sharma, A., Kumaran, M., Balarajah, S., Radhakrishnan, S. T., Sundramoorthi, R., Chung, C. M., Mummery, D., Alexander, J. L., Majeed, A., Hicks, L. C., & Williams, H. R. (2026). Evaluating the role of faecal calprotectin in older adults: a retrospective observational study. British Journal of General Practice. https://doi.org/10.3399/bjgp.2025.0169

Vancouver

Perry RW, Foulser PF, Zhang D, Martinez Perez P, Taylor S, Sharma A, et al. Evaluating the role of faecal calprotectin in older adults: a retrospective observational study. British Journal of General Practice. 2026. doi:10.3399/bjgp.2025.0169

BibTeX
@article{Perry2026,
  author = {Perry, Robert W and Foulser, Peter Fg and Zhang, David and Martinez Perez, Pablo and Taylor, Shakira and Sharma, Angelica and Kumaran, Mithun and Balarajah, Sharmili and Radhakrishnan, Shiva T and Sundramoorthi, Rohan and Chung, Carmen My and Mummery, David and Alexander, James L and Majeed, Azeem and Hicks, Lucy C and Williams, Horace Rt},
  title = {Evaluating the role of faecal calprotectin in older adults: a retrospective observational study},
  journal = {British Journal of General Practice},
  year = {2026},
  doi = {10.3399/bjgp.2025.0169}
}
Kostenlos starten →